Almudena Barbero-Castillo

Almudena Barbero-Castillo

Auto-generated profile, based on publicly available information

Almudena Barbero-Castillo

Systems Neuroscience, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS) , Barcelona 08036

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2021 in Advanced Science
Verified
Journal Article
Open access
PDF file
ABAlmudena Barbero‐Castillo
Almudena Barbero‐Castillo
FRFabio Riefolo
Fabio Riefolo
Carlo MateraCarlo Matera
Carlo Matera
SCSara Caldas‐Martínez
Sara Caldas‐Martínez
PMPedro Mateos‐Aparicio
Pedro Mateos‐Aparicio
PGPau Gorostiza
Pau Gorostiza
The ability to control neural activity is essential for research not only in basic neuroscience, as spatiotemporal control of activity is a fundamental experimental tool, but also in clinical neurology for therapeutic brain interventions. Transcranial‐magnetic, ultrasound, and alternating/direct current (AC/DC) stimulation are some available means of spatiotemporal controlled neuromodulation. There is also light‐mediated control, such as optogenetics, which has revolutionized neuroscience research, yet its clinical translation is hampered by the need for gene manipulation. As a drug‐based light‐mediated control, the effect of a photoswitchable muscarinic agonist (Phthalimide‐Azo‐Iper (PAI)) on a brain network is evaluated in this study. First, the conditions to manipulate M2 muscarinic receptors with light in the experimental setup are determined. Next, physiological synchronous emergent cortical activity consisting of slow oscillations—as in slow wave sleep—is transformed into a higher frequency pattern in the cerebral cortex, both in vitro and in vivo, as a consequence of PAI activation with light. These results open the way to study cholinergic neuromodulation and to control spatiotemporal patterns of activity in different brain states, their transitions, and their links to cognition and behavior. The approach can be applied to different organisms and does not require genetic manipulation, which would make it translational to humans.

8 February 2024 in Nanoscale Horizons
Verified
Journal Article
Open access
PDF file
ACA. Camassa
A. Camassa
ABA. Barbero-Castillo
A. Barbero-Castillo
MBMiquel Bosch
Miquel Bosch
MDM. Dasilva
M. Dasilva
EME. Masvidal-Codina
E. Masvidal-Codina
MSMaria V. Sanchez-Vives
Maria V. Sanchez-Vives
Graphene-based transistors (gSGFETs) enabled stable full-band brain recordings for 5+ months, allowing precise brain state identification and prediction, which is critical both in brain science and neurology.

15 January 2025 in PNAS Nexus
Verified
Journal Article
Open access
JSJosé Manuel Sánchez Sánchez
José Manuel Sánchez Sánchez
FRFabio Riefolo
Fabio Riefolo
ABAlmudena Barbero-Castillo
Almudena Barbero-Castillo
RSRosalba Sortino
Rosalba Sortino
LALuca Agnetta
Luca Agnetta
MSMaria V. Sanchez-Vives
Maria V. Sanchez-Vives
Acetylcholine and the cholinergic system are crucial to brain function, including functions such as consciousness and cognition. Dysregulation of this system is implicated in the pathophysiology of neurological conditions such as Alzheimer's disease. For this reason, cholinergic neuromodulation is relevant in both basic neuroscience and clinical neurology. In this study, we used photopharmacology to modulate neuronal activity using the novel selective type-1 muscarinic (M1) photoswitchable drugs: the agonist benzyl quinolone carboxylic acid-azo-iperoxo (BAI) and the antagonist cryptozepine-2. Our aim was to investigate the control over these cholinergic receptors using light and to investigate the effects of these drugs on physiological spontaneous slow waves and on epileptic activity in the cerebral cortex. First, we used transfected HEK cell cultures and demonstrated BAI’s preferential activation of M1 muscarinic acetylcholine receptors (mAChRs) compared with M2 mAChRs. Next, we found that white-light illumination of BAI increased the frequency of spontaneous slow-wave activity in brain cortical networks of both active slices and anesthetized mice, through M1-mAChRs activation. Illumination of cryptozepine-2 with UV light effectively suppressed not only the muscarinic-induced increase in slow-wave frequency, but also muscarinic-induced epileptiform discharges. These findings not only shed light on the role of M1 acetylcholine receptors in the cortical network dynamics but also lay the groundwork for developing advanced light-based pharmacological therapies. Photopharmacology offers the potential for high-precision spatiotemporal control of brain networks with high pharmacological specificity in both healthy and pathological conditions.

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
JSJosé Manuel Sánchez Sánchez
José Manuel Sánchez Sánchez
ABAlmudena Barbero-Castillo
Almudena Barbero-Castillo
FRFabio Riefolo
Fabio Riefolo
MSMaria V. Sanchez-Vives
Maria V. Sanchez-Vives
PGPau Gorostiza
Pau Gorostiza